Table 2.
Comparison of dependent variable means by study condition at pre- and post-test
| Pretest | Posttest | |||||
|---|---|---|---|---|---|---|
| Dependent variables | Experimental group | Control group | p | Experimental group | Control group | p |
| (n = 653) | (n = 599) | (n = 618) | (n = 430) | |||
| # of HIV Continuum Services Aware of | 1.23 (1.2) | 1.60 (1.3) | .000 | 1.39 (1.2) | 1.50 (1.3) | .137 |
| Staff Impact | 2.68 (1.2) | 2.91 (1.1) | .000 | 2.83 (1.2) | 2.90 (1.1) | .361 |
| HIV Medication and Pre-Release Planning | 4.22 (1.1) | 4.13 (1.1) | .142 | 4.11 (1.2) | 4.19 (1.0) | .255 |
| HIV Testing, Education, and Prevention | 3.55 (1.0) | 3.63 (0.9) | .197 | 3.62 (1.0) | 3.65 (1.0) | .608 |
| Consider going to HIV Education or getting tested for HIV | 2.00 (1.0) | 1.88 (0.9) | .031 | 1.90 (0.9) | 1.92 (1.0) | .756 |
| Concerned about getting HIV Infection | 3.81 (1.5) | 3.82 (1.5) | .918 | 3.87 (1.5) | 3.58 (1.5) | .002 |
Note. The mean values of groups on dependent variables are presented in the columns, with the standard deviations appearing in the parentheses immediately below the corresponding mean. Bonferroni adjustment to correct for an inflated Type 1 error rate (i.e., .05÷12 comparisons) yielded a significance level of p = .004. Therefore, interpretation of mean differences with associated significance levels above this are at a significantly increased risk for Type 1 error.